CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS

Authors

Keywords

Journal

Volume 83, Issue 20, Pages 1780-1788

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2014-09-20

DOI

10.1212/wnl.0000000000000926

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now